GYAN SINGH

16 Sanchong 1st Rd, House No 15, 2F, Hsinchu, Taiwan • gyan-med@outlook.com • (+886) 0976-041-016
SUMMARY
A highly skilled pharmaceutical formulation scientist with seven years of experience in developing and
optimizing formulations for various dosage forms. Proficient in a wide range of analytical techniques,
including HPLC, UV, Atomic Absorption Spectroscopy, GC, Polarography, Polarimeter, and Osmometer.
Knowledgeable in drug delivery systems, regulatory compliance, and project management. Possesses
strong analytical and problem-solving skills with a proven track record of successful project completion.
Excellent communication and collaboration skills, with the ability to work effectively with cross-functional
teams.

JOB RELATED SKILLS

 Formulation Development  Microsoft Office

 Drug Delivery Systems  Leadership
 Regulatory Compliance  Communication skills
 Organic Synthesis  Organisational skills

ANALYTICAL TECHNI QUES

 UV-Vis  Gas Chromatography

 FTIR  Polarimeter
 HPLC  Polar ography
 AAS  Osmometer
 Karl Fischer Titrators

PROFESSIONAL EXPERIENCE

Tai-Yu Chem. & Pharmaceutical Co., Ltd, Hsinchu, Taiwan Nov. 2018-Present
Senior Formulation Scientist
 Developed and optimized formulations for various dosage forms, including tablets, capsules, and
injectables.
 Conducted pre-formulation studies, stability testing, and compatibility assessments to determine
the feasibility and stability of potential formulations.
 Analyzed and interpreted data to draw conclusions and make recommendations for formulation
improvements.
 Collaborated with cross-functional teams, including research and development, manufacturing,
quality control, and regulatory affairs.
 Designed and executed experiments to support the development of new drug products, including
controlled release formulations, drug delivery systems, and novel drug combinations.

Tai-Yu Chem. & Pharmaceutical Co., Ltd, Hsinchu, Taiwan Sep. 2017-Oct. 2018
Associate Researcher (Regulatory Affairs)
 Regulatory Submission Preparation
 ACTD dossier compilation for new products
 Prepare SDS for pharmaceutical product
 A Periodic Safety Update Report
 Tai-Yu Chem. & Pharmaceutical Co., Ltd, Hsinchu, Taiwan Nov. 2015-Aug. 2017
Research Scientist (Formulation)
 Conducted research on novel drug delivery systems, including nanoparticles and liposomes.
 Developed and optimized analytical methods for characterizing drug products and formulations.
 Collaborated with cross-functional teams to design and execute experiments to support drug
product development.
 Analyzed and interpreted data to draw conclusions and make recommendations for formulation
improvements.

Research Assistance, Industrial Technology Research Institute (Part Oct2008-Dec 2009

Time ), Taiwan
 My research focus on the development of novel nanoparticle based drug delivery system. I was
involve in developing Super peroxide iron oxide nanoparticle, Graphene, Carbon Dot

Research Assistance, Delhi University, India Jan. 2006-July2006

 Assayed CD4+/CD3+ Lymphocyte Ratio in Patients with Bronchial Asthma Using Flow Cytometry

EDUCATION

PhD | 86.22 %
Molecular Medicine and Bio-Engineering Feb. 2010- Oct. 2015
National Yang Ming Chiao Tung University, Taiwan

MS| 84.09 %
Molecular Medicine and Bio-Engineering Oct. 2006- Sep. 2009
National Yang Ming Chiao Tung University, Taiwan

BSc (Hons)| 9.3/10

Biochemistry Jun. 2002- Jul. 2006
Allahabad Agriculture Institute-Deemed University

RESEARCH PUBLICATIONS

I. Singh G, Hsu KM, Chen YJ, Wu SC, Chen CY, Wang YM. A switch-on MRI contrast agent for
noninvasive visualization of methylmercury. Chem. Commun., 2015,51, 12032-12035 (IF:6.06)
II. Shiue, T. W.; Chen, Y. H.; Wu, C. M.; Singh, G.; Chen, H. Y.; Hung, C. H.; Liaw, W. F., Wang, Y. M. Nitric
Oxide Turn-on Fluorescent Probe Based on Deamination of Aromatic Primary Monoamines, Inorg.
Chem. 2012, 51, 5400-5408 (IF: 5.43)
III. Chen, S. H.; Kuo, Y. T.; Singh, G.; Cheng, T. L.; Su, Y. Z.; Wang, T. P.; Chiu, Y. Y.; Lai, J. J.; Chang, C. C.;
Jaw, T. S.; Tzou, S. C.; Liu, G. C.; Wang Y M. Development of a Gd(III)-Based Receptor-Induced
Magnetization Enhancement (RIME) Contrast Agent for β- Glucuronidase Activity Profiling. Inorg
Chem. 2012, 51, 12426–12435 (IF: 5.43)
IV. Wu, S. C.; Lin, K. L.; Wang, T. P.; Tzou, S. C.; Singh, G.; Chen, M. H.; Cheng, T. L.; Chen, C. Y.; Liu, G. C.;
Lee, T. W.; Hu, S. H.; Wang, Y.M. Imaging specificity of MR-optical imaging agents following the
masking of surface charge by poly(ethylene glycol). Biomaterials 2013, 34, 4118-4127. (IF: 15.3)
V. Tiwari, J. N.; Tiwari, R. N.; Singh, G. Recent progress in the development of anode and cathode
catalysts for direct methanol fuel cells, Nano. Energy 2013, 2, 553–578 (IF: 19.06)
VI. Chang, Y. H.; Chen, C.Y.; Singh, G.; Chen, H.Y.; Liu, G.C.; Goan, Y.G.; Aime, S.; Wang, Y. M. Synthesis
and Physicochemical Characterization of Carbon Backbone Modified [Gd(TTDA)(H2O)]2−derivatives,
Inorg. Chem. 2011, 50, 1275–1287 (IF: 5.43)
VII. Tiwari, J. N.; Tiwari, R. N.; Singh, G.; Lin, K. L. Direct Synthesis of Vertically Interconnected 3 – D
Graphitic Nanosheets on Hemispherical Carbon Particles by Microwave Plasma CVD. Plasmonics 2011,
6, 67–73 (IF: 2.72)

DISTINCTIONS

 Awarded Taiwan government fellowship to pursue MS in Molecular Medicine and Bioengineering

(Sep. 2006- Aug.2008)
 University fellowship for doctoral study (Feb. 2010-Feb.2014)
 National Science Council grant for doctoral research (Feb. 2010-Jun.2015)
 Granted honorary membership of The Phi Tau Phi Scholastic Honor Society of the Republic of China